Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Visby Medical has developed the world’s first instrument-free, single-use PCR diagnostic platform that delivers lab-quality results in under 30 minutes. Its Sexual Health Click Test for women is FDA-cleared and CLIA-waived for point-of-care use; the company recently received FDA De Novo authorization for the first-ever OTC at-home PCR sexual health test. The COVID‑19/Flu test is also available under emergency use authorization. Clinical studies have demonstrated high accuracy comparable to central lab PCR tests.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Visby Medical.